Developer of pharmaceutical drugs. The company's pharmaceutical drugs development services enable businesses to engage in the full cycle of drug development -- from exploratory research, clinical development, manufacturing and marketing. Its pipeline includes drug therapies for prostate cancer, breast cancer, pediatric ependymoma, overactive bladder and rheumatoid arthritis. read more

EMPLOYEE PARTICIPANTS: 15

TOTAL RATINGS: 123

CEO: Yoshihiko Hatanaka

Astellas Pharma CEO & Leadership Team Ratings

Yoshihiko Hatanaka and the Astellas Pharma leadership team are scored a "D-" by 13 employees placing it in the Bottom 10% of companies sized 10,000+ Employees. The Leadership Score of 45/100 is based on 27 ratings; it combines employee feedback on their CEO (49/100), Manager (46/100), and Executive Team (46/100).

Yoshihiko Hatanaka Astellas Pharma CEO Rating

Bottom 5% Compared to other companies of similar size

49 / 100

Yoshihiko Hatanaka the CEO of Astellas Pharma received an average score of 49 from Astellas Pharma employees.

Astellas Pharma Manager Rating

Bottom 5% Compared to other companies of similar size

46 / 100

Managers received an average score of 46 from Astellas Pharma employees.

Astellas Pharma Executive Team Rating

Bottom 10% Compared to other companies of similar size

D-

46 / 100

The Executive team received an average score of 46 from Astellas Pharma employees.

Rate your company